Former CEO of Pfizer Denmark will be the new director of RCT
One of Denmark's few female chief executives, Karin Verland, has been appointed as Director of the RCT.
Karin Verland has a background as CEO of pharmaceutical
companies like Pfizer, Janssen-Cilag A / S and Baxter and is the
former chairman of the Danish Association of the Pharmaceutical
Industry (LIF). She is a medical doctor and has received extensive
management training from leading international universities such as
Harvard and Cambridge. Right now she is completing an MBA at the
University of Leicester.
About her motivation to switch from business to a nonprofit
organization, Karin Verland says:
"For countless years I have spent many of my waking hours earning
money for shareholders. I gave a lot of myself without thinking of
where I was going. At one point I took some time to find direction
and reflect on what means something to me in life. "
The choice fell upon RCT and the fight for a world without torture
and organized violence, a territory that is not completely foreign
to the former member of the Danish Ethics Council.
"I am very concerned with how we humans treat each other, the
planet and the animals. There is something really wrong in our
world when we still torture each other. So for me it is very
natural to become the head of an organization whose values match
my own, "says Karin Verland.